Novo Nordisk Renames Rybelsus Pill to Ozempic in US
Idag, 15:03
Idag, 15:03
09:03 AM EDT, 05/01/2026 (MT Newswires) -- Novo Nordisk (NOVO-B.CO) on Friday said it renamed its oral semaglutide pill Rybelsus to Ozempic for easier recognition among diabetes patients and health workers.
Starting May 4, the relaunched and reformulated Ozempic tablets with 1.5-milligram, 4-milligram, and 9-milligram doses will be available in the US for adults with type 2 diabetes.
The Danish drugmaker said it will continue to market Rybelsus outside the US.
Idag, 15:03
09:03 AM EDT, 05/01/2026 (MT Newswires) -- Novo Nordisk (NOVO-B.CO) on Friday said it renamed its oral semaglutide pill Rybelsus to Ozempic for easier recognition among diabetes patients and health workers.
Starting May 4, the relaunched and reformulated Ozempic tablets with 1.5-milligram, 4-milligram, and 9-milligram doses will be available in the US for adults with type 2 diabetes.
The Danish drugmaker said it will continue to market Rybelsus outside the US.
Analys
Rapporter
OMX Stockholm 30
0,66%
(vid stängning)
OMX Stockholm 30
1 DAG %
Senast
3 060,48